Clinical Significance of Two Real-Time PCR Assays for Chronic Hepatitis C Patients Receiving Protease Inhibitor-Based Therapy

• Takako Inoue,

  Affiliation Department of Clinical Laboratory, Nagoya City University Hospital, Nagoya, Japan

  ⨯
• Su Su Hmwe,

  Affiliation Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan

  ⨯
• Noritomo Shimada,

  Affiliations Ootakanomori Hospital, Kashiwa, Japan, Division of Gastroenterology and Hepatology, Shin-Matsudo Central General Hospital, Matsudo, Japan

  ⨯
• Keizo Kato,

  Affiliation Division of Gastroenterology and Hepatology, Shin-Matsudo Central General Hospital, Matsudo, Japan

  ⨯
• Tatsuya Ide,

  Affiliation Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

  ⨯
• Takuji Torimura,

  Affiliation Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan

  ⨯
• Takashi Kumada,

  Affiliation Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan

  ⨯
• Hidenori Toyoda,

  Affiliation Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan

  ⨯
• Akihito Tsubota,

  Affiliation Institute of Clinical Medicine and Research, The Jikei University School of Medicine, Kashiwa, Japan

  ⨯
• Koichi Takaguchi,

  Affiliation Department of Hepatology, Kagawa Prefectural Central Hospital, Takamatsu, Japan

  ⨯
• Takaji Wakita,

  Affiliation Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan

  ⨯
• Yasuhito Tanaka

  * E-mail: ytanaka@med.nagoya-cu.ac.jp

  Affiliations Department of Clinical Laboratory, Nagoya City University Hospital, Nagoya, Japan, Department of Virology and Liver Unit, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

  ⨯